Press Release BIOMATLANTE obtains CE approval to market its OSTEOTWIN™ Affix Sheath

25 June 2015

BIOMATLANTE (Vigneux de Bretagne ), a medical devices company specialized in bone regeneration and member of Atlanpole Biotherapies, today announced the CE regulatory approval of OSTEOTWIN™ Affix Sheath 1, combining a polymer with its MBCP™ core technology, to significantly enhance fixation strength and graft protection. This product is the result of a development partnership between BIOMATLANTE and AMPLITUDE (Valence).

Read the full press release